FI77461B - Foerfarande foer framstaellning av nya (8s)-8-fluorierytromycinderivat. - Google Patents

Foerfarande foer framstaellning av nya (8s)-8-fluorierytromycinderivat. Download PDF

Info

Publication number
FI77461B
FI77461B FI850828A FI850828A FI77461B FI 77461 B FI77461 B FI 77461B FI 850828 A FI850828 A FI 850828A FI 850828 A FI850828 A FI 850828A FI 77461 B FI77461 B FI 77461B
Authority
FI
Finland
Prior art keywords
fluoroerythromycin
formula
salt
methyl
esters
Prior art date
Application number
FI850828A
Other languages
English (en)
Finnish (fi)
Other versions
FI77461C (sv
FI850828A0 (fi
FI850828L (fi
Inventor
Luciano Toscano
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of FI850828A0 publication Critical patent/FI850828A0/fi
Publication of FI850828L publication Critical patent/FI850828L/fi
Application granted granted Critical
Publication of FI77461B publication Critical patent/FI77461B/fi
Publication of FI77461C publication Critical patent/FI77461C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Amplifiers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Claims (7)

1. Förfarande för framställning av som läkemedel användbara föreningar med formeln I 5 CH3 CH, N: / N 10 fch3
15 CH3</* (C"CH3 (I) CH3 Y CH3 ] j S<; oh 20 ch3 or' 25. vilken formel R är en rakkedjad eller förgrenad (C^-C^)alkyl R' är väte eller metyl; och R" är hydroxl, 30 samt de motsvarande farmaceutiskt godtagbara estrarna, addltlonssalterna av de organlska syrorna samt saltestrarna, kännetecknat därav, att förfarandet innefattar fluorering av en lösning av 8,9-anhydroerytromycin 6,9-hemiketal eller motsvarande N-oxid enligt formel II II 21 774 61 ctfu
5. I jn ho^ A ch3*J^'J/CHj cr^tr^cH-hcl Ar-" 3 10 ch^IcA jL >=) jQ^CH, (ID ?u K 3 . CHJ 'Vch,'''^°νCH3 1 ζΧ„ ch3 or* 20 varvid i nämnda formel R’ och R” är i enlighet med vad som presenterades i patentkravet I och x är 0 eller 1, med perklorylfluorid i närvaro av 25 en ekvimolära mängd av en förening med formeln RÖH, där R Mr 1 enlighet med vad som deflnlerades i patentkravet 1, i strikt anhydriska förhallan-den, och det erhallna mellanskedet reduceras, da x är 1, och valbart den erhällna föreningen överförs till dess farmaceutiskt godtagbara ester, salt eller saltester. 30
2. Forfarande enligt patentkravet 1, kännetecknat därav, att R’ Mr metyl.
3. Forfarande enligt patentkravet 1, kännetecknat därav, att 35 <jen absolute konfigurationen i C-9 är R.
4. Forfarande enligt patentkravet 1, kännetecknat därav, att
FI850828A 1984-03-08 1985-02-28 Förfarande för framställning av nya (8S)-8-fluorierytromycinderivat. FI77461C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19950/84A IT1196041B (it) 1984-03-08 1984-03-08 Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
IT1995084 1984-03-08

Publications (4)

Publication Number Publication Date
FI850828A0 FI850828A0 (fi) 1985-02-28
FI850828L FI850828L (fi) 1985-09-09
FI77461B true FI77461B (fi) 1988-11-30
FI77461C FI77461C (sv) 1989-03-10

Family

ID=11162576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850828A FI77461C (sv) 1984-03-08 1985-02-28 Förfarande för framställning av nya (8S)-8-fluorierytromycinderivat.

Country Status (8)

Country Link
US (1) US4588712A (sv)
EP (1) EP0158102B1 (sv)
JP (1) JPH0641477B2 (sv)
AT (1) ATE41012T1 (sv)
CA (1) CA1229591A (sv)
DE (1) DE3568440D1 (sv)
FI (1) FI77461C (sv)
IT (1) IT1196041B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876245A (en) * 1986-12-22 1989-10-24 Daikin Industries Ltd. Fluorine-containing macrolide compounds and their use
MY103197A (en) * 1987-02-20 1993-05-29 Kitasato Inst A growth promoting composition and production thereof
US6047808A (en) * 1996-03-07 2000-04-11 Coinstar, Inc. Coin sensing apparatus and method
US6168001B1 (en) 1997-06-27 2001-01-02 Coinstar, Inc. Positive drive coin discrimination apparatus and method
US7066335B2 (en) * 2001-12-19 2006-06-27 Pretech As Apparatus for receiving and distributing cash
JP2006528689A (ja) * 2003-05-06 2006-12-21 ムルイェ、ニルマル エリスロマイシン誘導体の徐放製剤
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
CA2632779A1 (en) * 2005-12-08 2007-06-14 Pfizer Inc. Method for demethylating the 3'-dimethylamino group of erythromycin compounds
CN101547931B (zh) 2006-12-05 2012-11-14 辉瑞有限公司 促动内酯多晶型
US9036890B2 (en) 2012-06-05 2015-05-19 Outerwall Inc. Optical coin discrimination systems and methods for use with consumer-operated kiosks and the like
US8967361B2 (en) 2013-02-27 2015-03-03 Outerwall Inc. Coin counting and sorting machines
US9022841B2 (en) 2013-05-08 2015-05-05 Outerwall Inc. Coin counting and/or sorting machines and associated systems and methods
US9235945B2 (en) 2014-02-10 2016-01-12 Outerwall Inc. Coin input apparatuses and associated methods and systems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056291B1 (en) * 1981-01-09 1986-01-08 Pierrel S.p.A. Novel semisynthetic macrolidic antibiotics, microbiological processes for their preparation and related microorganism, novel intermediate compounds for their preparation and related pharmaceutical compositions containing them
IT1195299B (it) * 1981-11-27 1988-10-12 Pierrel Spa Procedimento chimico di sintesi per la preparazione di antibiotici macrolidici
JPS5896098A (ja) * 1981-12-03 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンa誘導体

Also Published As

Publication number Publication date
FI77461C (sv) 1989-03-10
EP0158102B1 (en) 1989-03-01
CA1229591A (en) 1987-11-24
EP0158102A3 (en) 1986-03-19
ATE41012T1 (de) 1989-03-15
FI850828A0 (fi) 1985-02-28
IT1196041B (it) 1988-11-10
JPS60208995A (ja) 1985-10-21
US4588712A (en) 1986-05-13
DE3568440D1 (en) 1989-04-06
IT8419950A0 (it) 1984-03-08
JPH0641477B2 (ja) 1994-06-01
FI850828L (fi) 1985-09-09
EP0158102A2 (en) 1985-10-16

Similar Documents

Publication Publication Date Title
FI77461B (fi) Foerfarande foer framstaellning av nya (8s)-8-fluorierytromycinderivat.
JPH09505596A (ja) ラパマイシンの複素環式エステルおよびそれらを含有する医薬組成物
AU607100B2 (en) New androstane 17-carboxylic acid ester, process for their preparation and drugs containing them
NZ235053A (en) Epipodophyllotoxin altroside derivatives
HU205132B (en) Process for producing fluorine-substituted epipodophyllotoxin glycosides and pharmaceutical compositions comprising same as active ingredient
WO1996012727A1 (fr) Derives hydrosolubles d&#39;epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
US4108996A (en) (-)-Apovincaminol lauric acid ester and cerebral vasodilatory composition thereof
US6787571B2 (en) Anti-inflammatory compounds derived from Pseudopterorgorgia elisabethae
CA2005134A1 (en) Compounds
EP0136831A2 (en) Azahomoerythromycin B derivatives and intermediates thereof
WO2000064915A1 (en) Novel disaccharide antibacterial agents
EP0104631B1 (en) Clavulone derivatives, process for preparing the same, and use of said compounds
US5096905A (en) Basic cleavage products of elaiophylin and elaiophylin derivatives and use thereof
GB2327084A (en) 9a-Aza-3-ketolide antibiotics
EP0434376A2 (en) Ivermectin derivative compounds and process for preparing the same
DE69314947T2 (de) 2-aminozuckermakrolid-derivate
IT9022047A1 (it) 13-desosso-4&#39;-desossi-4&#39;-iodoantracicline
HU203743B (en) Process for producing demalonyl-derivatives of macrolide-lactones
EP0490311B1 (en) Derivatives of 10,11,12,13-tetra-hydrodesmycosin, processes for preparation, and use thereof in obtaining pharmaceuticals
JP2640239B2 (ja) プロトスタ−13(17)エン−3,16−ジオン化合物
WO1993016090A1 (en) Amphotericin b derivative
GB2246568A (en) Tricyclo compound, a process for its production and a pharmaceutical composition containing the same
CS199728B2 (en) Method of producing derivatives of 4&#34;-sulphonyl amino oleandomycin
KR0180565B1 (ko) 2-아미노-9-(1,3-디하이드록시-2-프로폭시메틸)-6-플루오로퓨린 에스테르 유도체
CA2203155C (fr) Derives hydrosolubles d&#39;epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PIERREL S.P.A.